Calamos Advisors LLC bought a new position in AvePoint, Inc. (NASDAQ:AVPT – Free Report) during the 4th quarter, HoldingsChannel reports. The firm bought 153,442 shares of the company’s stock, valued at approximately $1,260,000.
Several other hedge funds also recently bought and sold shares of AVPT. Vanguard Group Inc. increased its position in shares of AvePoint by 227.8% in the 1st quarter. Vanguard Group Inc. now owns 10,390,928 shares of the company’s stock valued at $54,656,000 after buying an additional 7,220,811 shares in the last quarter. BlackRock Inc. raised its position in shares of AvePoint by 32.6% during the second quarter. BlackRock Inc. now owns 10,382,686 shares of the company’s stock worth $59,804,000 after purchasing an additional 2,553,858 shares during the period. State Street Corp lifted its holdings in shares of AvePoint by 243.5% during the 2nd quarter. State Street Corp now owns 2,143,383 shares of the company’s stock valued at $9,302,000 after purchasing an additional 1,519,449 shares in the last quarter. JPMorgan Chase & Co. grew its position in shares of AvePoint by 949.7% in the 2nd quarter. JPMorgan Chase & Co. now owns 1,550,288 shares of the company’s stock valued at $8,930,000 after purchasing an additional 1,402,604 shares during the period. Finally, Bank of New York Mellon Corp increased its stake in AvePoint by 274.5% during the 3rd quarter. Bank of New York Mellon Corp now owns 1,835,402 shares of the company’s stock worth $12,334,000 after purchasing an additional 1,345,267 shares in the last quarter. 44.49% of the stock is currently owned by institutional investors and hedge funds.
Insider Activity at AvePoint
In related news, insider Brian Michael Brown sold 20,000 shares of the stock in a transaction that occurred on Friday, March 1st. The stock was sold at an average price of $8.11, for a total transaction of $162,200.00. Following the completion of the transaction, the insider now directly owns 1,286,088 shares of the company’s stock, valued at $10,430,173.68. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Over the last quarter, insiders have sold 43,061 shares of company stock valued at $342,288. 27.78% of the stock is owned by insiders.
Wall Street Analyst Weigh In
Check Out Our Latest Stock Analysis on AVPT
AvePoint Stock Up 0.1 %
Shares of AVPT opened at $7.69 on Monday. AvePoint, Inc. has a twelve month low of $4.01 and a twelve month high of $8.61. The stock has a market capitalization of $1.42 billion, a P/E ratio of -64.08 and a beta of 0.85. The company has a 50 day moving average of $7.86 and a 200-day moving average of $7.88.
AvePoint (NASDAQ:AVPT – Get Free Report) last released its earnings results on Thursday, February 29th. The company reported $0.02 earnings per share for the quarter, missing analysts’ consensus estimates of $0.03 by ($0.01). AvePoint had a negative net margin of 7.94% and a negative return on equity of 9.94%. The business had revenue of $74.60 million during the quarter, compared to the consensus estimate of $71.57 million. During the same period last year, the business posted ($0.07) EPS. The firm’s revenue for the quarter was up 17.3% on a year-over-year basis. On average, sell-side analysts anticipate that AvePoint, Inc. will post -0.15 earnings per share for the current fiscal year.
AvePoint Profile
AvePoint, Inc provides cloud-native data management software platform in North America, Europe, Middle East, Africa, and Asia Pacific. It also offers software-as-a-service solutions and productivity applications. The company offers modularity and cloud services architecture to address critical challenges and the management of data to organizations that leverage third-party cloud vendors, including Microsoft, Salesforce, Google, AWS, Box, DropBox, and others; license and support; and maintenance services.
Further Reading
- Five stocks we like better than AvePoint
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Intuitive Surgical Leads the Robotic Surgery Movement
- Stock Market Upgrades: What Are They?
- Wegovy vs. Zepbound: Who Wins the Battle of the GLP-1 Drugs?
- What are earnings reports?
- MarketBeat Week in Review – 4/15 – 4/19
Want to see what other hedge funds are holding AVPT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AvePoint, Inc. (NASDAQ:AVPT – Free Report).
Receive News & Ratings for AvePoint Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AvePoint and related companies with MarketBeat.com's FREE daily email newsletter.